4.5 Article

Evaluation of Patient Compliance, Quality of Life Impact and Cost-Effectiveness of a Test In-Train Out Exercise-Based Rehabilitation Program for Patients With Intermittent Claudication

期刊

CIRCULATION JOURNAL
卷 75, 期 9, 页码 2128-2134

出版社

JAPANESE CIRCULATION SOC
DOI: 10.1253/circj.CJ-10-1311

关键词

Cost-effectiveness; Exercise; Peripheral arterial disease; Quality of Life; Rehabilitation

资金

  1. University of Ferrara, Ferrara, Italy

向作者/读者索取更多资源

Background: Patients with intermittent claudication (IC) could benefit from low-cost, effective rehabilitative programs. This retrospective study evaluates compliance, impact on Quality of Life (QoL) and cost-effectiveness of a hospital prescribed, at-home performed (Test-in/Train-out) rehabilitative program for patients with IC. Methods and Results: Two-hundred and eighty-nine patients with IC (71 +/- 10.1 years, M=210) were enrolled for a 2-year period. Two daily 10-min home walking sessions at maximal asymptomatic speed were prescribed, with serial check-ups at the hospital. Compliance with the program was assessed by assigning a score of 1 (lowest compliance) to 4 (highest compliance). The SF-36 questionnaire and a constant-load treadmill test were used to evaluate QoL and Initial/Absolute Claudication Distance, respectively. Both direct and indirect costs of the program were considered for cost-effectiveness analysis. Two-hundred and fifty patients (70.5 +/- 9.2 years, M=191), at Fontaine's II-B stage (86%), were included in the study. No adverse events were reported. The average compliance score was 3.1. At discharge, both SF-36 domains and walking performance significantly increased (P<0.0001). A total of 1,839 in-hospital check-ups (7.36 /patient) were performed. Direct and indirect costs represented 93% and 7% of the total costs, respectively. The average costs of a visit and of a therapy cycle were 668.93 and (sic)507.20, respectively. The cost to walk an additional meter before stopping was (sic)9.22. Conclusions: A Test-in/Train-out program provided favourable patient compliance, QoL impact and cost-effectiveness in patients with IC. (Circ J 2011; 75: 2128-2134)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据